Supplementary Figure 2 from HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors

作者：Elicia Penuel, Congfen Li, Vaishali Parab, Luciana Burton, Kyra J. Cowan, Mark Merchant, Robert L. Yauch, Premal Patel, Amy Peterson, Garret M. Hampton, Mark R. Lackner, Priti S. Hegde · 年份：2023 · DOI：10.1158/1535-7163.22499676.v1 · 研究领域：Cytokine Signaling Pathways and Interactions、Fibroblast Growth Factor Research、Chemokine receptors and signaling

<p>PDF file - 24K, cHGF levels are stable over time and are not variable between screening (any time during visit -24 hours) and predose (Day 0).</p>